Form 4 for STAA STAAR SURGICAL CO
Accepted 2021-09-03 00:00:00 ET · period of report 2021-09-01 · accession 0001209191-21-054675 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-03 | 2021-09-01+ | STAA | Blickensdoerfer Hans-Martin | SVP, Comm. Ops, China | M - OptEx | $23.12 | +34.9K | 103.1K | +51% | +$807.2K |
| DM | 2021-09-03 | 2021-09-01+ | STAA | Blickensdoerfer Hans-Martin | SVP, Comm. Ops, China | S - Sale+OE | $157.55 | -54.6K | 88.7K | -38% | -$8.60M |
| DM | 2021-09-03 | 2021-09-01+ | STAA | Blickensdoerfer Hans-Martin | SVP, Comm. Ops, China | M - OptEx | $0.00 | -34.9K | 18.1K | -66% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-01 | M | A | 17,573 | $16.15 | 117,333 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-02 | M | A | 871 | $16.15 | 89,593 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-01 | S | D | 8,621 | $157.61 | 99,760 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.50 to $157.99, inclusive. |
| 4 | Common | Common Stock | 2021-09-01 | S | D | 17,573 | $157.61 | 99,760 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.50 to $157.99, inclusive. |
| 5 | Common | Common Stock | 2021-09-02 | S | D | 11,038 | $157.50 | 88,722 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.50 to $157.56, inclusive. |
| 6 | Common | Common Stock | 2021-09-02 | S | D | 17,343 | $157.50 | 88,722 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.50 to $157.72, inclusive. |
| 7 | Common | Common Stock | 2021-09-02 | M | A | 2,988 | $35.98 | 106,065 | D | — | — | |
| 8 | Common | Common Stock | 2021-09-02 | M | A | 13,484 | $29.80 | 103,077 | D | — | — | |
| 9 | Derivative | Common Stock Options | 2021-09-01 | M | D | 17,573 | $0.00 | 871 | D | $16.15 · 2019-03-15 to 2028-03-14 | 17,573 Common Stock | |
| 10 | Derivative | Common Stock Options | 2021-09-02 | M | D | 871 | $0.00 | 0 | D | $16.15 · 2019-03-15 to 2028-03-14 | 871 Common Stock | |
| 11 | Derivative | Common Stock Options | 2021-09-02 | M | D | 13,484 | $0.00 | 0 | D | $29.80 · 2019-06-14 to 2028-06-13 | 13,484 Common Stock | |
| 12 | Derivative | Common Stock Options | 2021-09-02 | M | D | 2,988 | $0.00 | 18,140 | D | $35.98 · 2020-03-14 to 2029-03-13 | 2,988 Common Stock | (F5) The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/13/2029. |